Company: DARE
Filing Date: 2025-04-24
Form Type: ARS
Source: 0001401914-25-000018
Chunk: 264

Company: Dare Bioscience, Inc.
Filing Date: 2025-04-24
Form: ARS
Chunk 264
---
 to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. Signature Title Date /s/ SABRINA MARTUCCI JOHNSON President and Chief Executive Officer (Principal Executive Officer and Principal Financial Officer) and Director March 31, 2025 Sabrina Martucci Johnson /s/ MARDEE HARING-LAYTON Chief Accounting Officer March 31, 2025 MarDee Haring-Layton (Principal Accounting Officer) /s/ WILLIAM H. RASTETTER Chairman of the Board and Director March 31, 2025 William H. Rastetter, Ph.D. /s/ JESSICA D. GROSSMAN Director March 31, 2025 Jessica D. Grossman, M.D. /s/ SUSAN L. KELLEY Director March 31, 2025 Susan L. Kelley, M.D. /s/ GREGORY W. MATZ Director March 31, 2025 Gregory W. Matz, CPA /s/ ROBIN STEELE Director March 31, 2025 Robin Steele, J.D., L.L.M. 141

DARÉ BIOSCIENCE, INC. AND SUBSIDIARIES INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Page Report of Independent Registered Public Accounting Firm (PCAOB ID 200) F-2 Consolidated Balance Sheets as of December 31, 2024 and 2023 F-4 Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2024 and 2023 F-5 Consolidated Statements of Stockholders’ Equity (Deficit) for the years ended December 31, 2024 and 2023 F-6 Consolidated Statements of Cash Flows for the years ended December 31, 2024 and 2023 F-7 Notes to Consolidated Financial Statements F-8 F-1

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Board of Directors and Stockholders Daré Bioscience, Inc. Opinion on the Consolidated Financial Statements We have audited the accompanying consolidated balance sheets of Daré Bioscience, Inc. and Subsidiaries (the “Company”) as of December 31, 2024 and 2023, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity (def